Literature DB >> 17268027

Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI.

Takahiro Higuchi1, Stephan G Nekolla, Antanas Jankaukas, Axel W Weber, Marc C Huisman, Sybille Reder, Sibylle I Ziegler, Markus Schwaiger, Frank M Bengel.   

Abstract

UNLABELLED: The combination of small-animal PET and MRI data provides quantitative in vivo insights into cardiac pathophysiology, integrating information on biology and morphology. We sought to determine the feasibility of PET and MRI for the quantification of ischemic injury in the rat model.
METHODS: Fourteen healthy male Wistar rats were studied with 18F-FDG PET and cine MRI. Myocardial viability was determined in a transmural myocardial infarction model in 12 additional rats, using 18F-FDG PET and delayed-enhancement MRI with gadolinium-diethylenetriaminepentaacetic acid. All PET was acquired with a dedicated small-animal PET system. MRI was performed on a 1.5-T clinical tomograph with a dedicated small-animal electrocardiographic triggering device and a small surface coil.
RESULTS: In normal rats, 18F-FDG uptake was homogeneous throughout the left ventricle. The lowest mean uptake of the 18F-FDG was found in the apical regions (79% +/- 6.0% of maximum) and the highest uptake was in the anterior wall (93% +/- 4.3 % of maximum). Myocardial infarct size as determined by histology correlated well with defects of glucose metabolism obtained with 18F-FDG PET (r = 0.89) and also with delayed-enhancement MRI (r = 0.91). Left ventricular ejection fraction in normal rats measured by cine MRI was 57% +/- 5.4% and decreased to 38% +/- 12.9% (P < 0.001) in the myocardial infarction model.
CONCLUSION: Integrating information from small-animal PET and clinical MRI instrumentation allows for the quantitative assessment of cardiac function and infarct size in the rat model. The MRI measurements of scar can be complemented by metabolic imaging, addressing the extent and severity of ischemic injury and providing endpoints for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17268027

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  34 in total

1.  Small-animal molecular imaging methods.

Authors:  Robert A de Kemp; Frederick H Epstein; Ciprian Catana; Benjamin M W Tsui; Erik L Ritman
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

Review 2.  Monitoring left ventricular function in small animals.

Authors:  Tony Lahoutte
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 3.  PET and MRI in cardiac imaging: from validation studies to integrated applications.

Authors:  Stephan G Nekolla; Axel Martinez-Moeller; Antti Saraste
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

Review 4.  The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations.

Authors:  Timm Dickfeld; Christopher Kocher
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

5.  Myocardial perfusion imaging is feasible for infarct size quantification in mice using a clinical single-photon emission computed tomography system equipped with pinhole collimators.

Authors:  Tim Wollenweber; Christian Zach; Christoph Rischpler; Rebekka Fischer; Sebastian Nowak; Stephan G Nekolla; Michael Gröbner; Christopher Ubleis; Gerald Assmann; Josef Müller-Höcker; Christian La Fougére; Guido Böning; Paul Cumming; Wolfgang-Michael Franz; Marcus Hacker
Journal:  Mol Imaging Biol       Date:  2009-11-25       Impact factor: 3.488

6.  CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study.

Authors:  Raffaele Altara; Marco Manca; Marleen H Hessel; Yumei Gu; Laura C van Vark; K Martijn Akkerhuis; Jan A Staessen; Harry A J Struijker-Boudier; George W Booz; W Matthijs Blankesteijn
Journal:  J Cardiovasc Transl Res       Date:  2016-06-06       Impact factor: 4.132

7.  Cardiac PET/CT for the evaluation of known or suspected coronary artery disease.

Authors:  Marcelo F Di Carli; Venkatesh L Murthy
Journal:  Radiographics       Date:  2011 Sep-Oct       Impact factor: 5.333

Review 8.  Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.

Authors:  Shreya Goel; Christopher G England; Feng Chen; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2016-08-09       Impact factor: 15.470

9.  Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts.

Authors:  Christoph Rischpler; Kenji Fukushima; Takuro Isoda; Mehrbod S Javadi; Robert F Dannals; Roselle Abraham; Richard Wahl; Frank M Bengel; Takahiro Higuchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-03-29       Impact factor: 9.236

10.  Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation.

Authors:  Vincenzo Lionetti; Silvia Cantoni; Claudia Cavallini; Francesca Bianchi; Sabrina Valente; Irene Frascari; Elena Olivi; Giovanni D Aquaro; Francesca Bonavita; Ignazio Scarlata; Margherita Maioli; Valentina Vaccari; Riccardo Tassinari; Antonietta Bartoli; Fabio A Recchia; Gianandrea Pasquinelli; Carlo Ventura
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.